Microsomal Prostaglandin E Synthase-1 (mPGES-1) is involved in the metabolic and cardiovascular alterations associated with obesity.
Constanza Ballesteros-MartinezRaquel Rodrigues-DiezLuis M BeltránRosa Moreno-CarrilesErnesto Martínez-MartínezMaría González-AmorJose Martínez-GonzálezCristina RodríguezVictoria CachofeiroMercedes SalaicesAna M BrionesPublished in: British journal of pharmacology (2021)
mPGES-1 inhibition might be a novel therapeutic approach for the management of obesity and the associated cardiovascular and metabolic alterations.